# Semaglutide shows cardiovascular benefits for overweight adults with impaired kidney function – A recent study published in the New England Journal of Medicine suggests semaglutide, a medication commonly used for weight management, may also have cardiovascular benefits for overweight adults with impaired kidney function. – The study involved over 3,000 participants with an average body mass index (BMI) of 37. – Participants who received semaglutide had a lower rate of cardiovascular events compared to those who received a placebo. – Further research is needed to explore the potential benefits of semaglutide for individuals with both obesity and impaired kidney function. ## The implications of the study This study sheds light on the potential cardiovascular benefits of semaglutide beyond just weight management. It suggests that this medication could be a valuable option for overweight individuals with impaired kidney function who are at risk of cardiovascular events. ### Our thoughts The findings of this study are promising and open up new possibilities for the use of semaglutide in addressing not only weight management but also cardiovascular health. If you are considering weight loss options and have impaired kidney function, it may be worth discussing the potential benefits of semaglutide with your healthcare provider. Weight loss disclaimer: Individual results may vary. Mindful Evolution does telehealth in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. Contact Mindful Evolution on our website https://yourmindfulevolution.com or call/text us at 954-639-9960 for personalized advice and support.